Published in Am J Hum Genet on April 11, 2001
Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer. Prostate (2008) 1.12
Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb. Hum Genet (2007) 1.10
Genome-wide linkage scan for prostate cancer susceptibility genes in men with aggressive disease: significant evidence for linkage at chromosome 15q12. Hum Genet (2006) 0.96
Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect. Hum Genet (2005) 0.91
Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer. J Med Genet (2004) 0.90
Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families. Proc Natl Acad Sci U S A (2004) 0.89
Prostate cancer susceptibility loci: finding the genes. Adv Exp Med Biol (2008) 0.87
Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance. Hum Genet (2007) 0.84
NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene. BMC Cancer (2011) 0.80
Inherited predisposition to prostate cancer. Eur J Epidemiol (2003) 0.79
Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer. Cancer Lett (2008) 0.79
Genetic susceptibility to prostate cancer: a review. Fam Cancer (2003) 0.78
Food Habits, Lifestyle Factors, and Risk of Prostate Cancer in Central Argentina: A Case Control Study Involving Self-Motivated Health Behavior Modifications after Diagnosis. Nutrients (2016) 0.76
The clinical genetics of prostate cancer. Hered Cancer Clin Pract (2004) 0.75
Association of a single-nucleotide polymorphism from chromosome 17q12 with the aggressiveness of prostate cancer in a Hispanic population. J Cancer Res Clin Oncol (2014) 0.75
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol (1988) 13.73
A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst (1994) 6.27
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (1996) 5.06
Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst (1997) 3.92
Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev (1999) 3.29
Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A (1992) 3.28
Family history and the risk of prostate cancer. Prostate (1990) 3.27
Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet (1998) 2.90
Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med (1995) 2.83
Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet (1997) 2.77
Segregation and linkage analysis of nine Utah breast cancer pedigrees. Genet Epidemiol (1988) 2.65
Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet (1998) 2.59
The impact of family history on early detection of prostate cancer. Nat Med (1995) 2.14
Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet (1999) 2.12
Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol (1995) 2.04
An investigation of the familial aspects of carcinoma of the prostate. Cancer (1960) 1.75
Asymptomatic incidence and duration of prostate cancer. Am J Epidemiol (1998) 1.68
Association of HPC2/ELAC2 genotypes and prostate cancer. Am J Hum Genet (2000) 1.65
Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet (2000) 1.64
Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet (1998) 1.63
Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet (2000) 1.58
Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer (1995) 1.43
After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet (2000) 1.34
Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer (1996) 1.30
Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Am J Epidemiol (1997) 1.29
Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev (1999) 1.28
Familial patterns of covariation for cardiovascular risk factors in adults: The Victorian Family Heart Study. Am J Epidemiol (2000) 1.23
Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst (1997) 1.23
Heredity and prostate cancer: a study of World War II veteran twins. Prostate (1997) 1.22
Studies of genetic factors in prostate cancer in a twin population. J Urol (1994) 1.13
Family history and prostate cancer risk. Am J Epidemiol (1996) 1.07
Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study. Cancer Epidemiol Biomarkers Prev (2000) 1.07
Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus. Cancer Res (2000) 1.06
Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer. Urology (1996) 1.01
Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer (1999) 0.98
Family history of prostate cancer: a multi-center case-control study in Canada. Int J Cancer (1997) 0.93
The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: a population-based cohort study. Eur J Cancer (1997) 0.82
A case-cohort study on prostate cancer risk in relation to family history of prostate cancer. Epidemiology (1999) 0.82
Family studies and the evidence for genetic susceptibility to prostate cancer. Semin Cancer Biol (1997) 0.78
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet (1982) 7.07
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
The Melbourne Collaborative Cohort Study. IARC Sci Publ (2002) 3.45
Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev (1999) 3.29
Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust (1993) 3.28
A prospective population-based study of menopausal symptoms. Obstet Gynecol (2000) 3.27
Genetic determinants of bone mass in adults. A twin study. J Clin Invest (1987) 3.23
Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res (1999) 3.11
Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma. Int J Epidemiol (1996) 2.91
Meta-analysis of alcohol and all-cause mortality: a validation of NHMRC recommendations. Med J Aust (1996) 2.68
Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med (1993) 2.61
Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees. Australian Breast Cancer Family Study. Nat Genet (2000) 2.43
Sexual factors and prostate cancer. BJU Int (2003) 2.38
Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol (1995) 2.37
Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut (2005) 2.37
The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study. Cancer (1998) 2.34
A psychometric experiment in causal inference to estimate evidential weights used by epidemiologists. Epidemiology (2001) 2.30
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol (1994) 2.15
Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab (1999) 2.13
Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis (1990) 2.12
The quantification of mortality resulting from the regular use of illicit opiates. Addiction (1999) 2.10
Breast cancer in Australian women under the age of 40. Cancer Causes Control (1998) 2.08
The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab (1995) 2.07
Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet (2012) 2.06
A review of the effects of random measurement error on relative risk estimates in epidemiological studies. Int J Epidemiol (1989) 2.05
Prostate cancer in Victoria in 1993: patterns of reported management. Med J Aust (2000) 2.00
Factors in childhood as predictors of asthma in adult life. BMJ (1994) 2.00
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br J Cancer (2010) 1.99
How receptive are patients to medical students in Australian hospitals? A cross-sectional survey of a public and a private hospital. Intern Med J (2013) 1.96
Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr (1999) 1.95
The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma. Cancer (1992) 1.95
Epileptic seizures in acute stroke. Arch Neurol (1990) 1.94
Dementia in elderly outpatients: a prospective study. Ann Intern Med (1984) 1.92
Changes in the investigation and management of primary operable breast cancer in Victoria. Med J Aust (1994) 1.92
Preoperative MRI predicts outcome of temporal lobectomy: an actuarial analysis. Neurology (1995) 1.91
Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol (1998) 1.91
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91
Respiratory symptoms in Tasmanian adolescents: a follow up of the 1961 birth cohort. Aust N Z J Med (1984) 1.88
Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia. Int J Cancer (1995) 1.88
Sun exposure and non-melanocytic skin cancer. Cancer Causes Control (1994) 1.83
Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer (1999) 1.83
BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer. Br J Cancer (1999) 1.71
Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group. Med J Aust (2000) 1.71
Reduced bone mass in daughters of women with osteoporosis. N Engl J Med (1989) 1.70
CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer Inst (2000) 1.69
Hormone replacement therapy and accuracy of mammographic screening. Lancet (2000) 1.68
A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab (2000) 1.66
Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations. Br J Cancer (2010) 1.65
Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer (1996) 1.57
Power of regression and maximum likelihood methods to map QTL from sib-pair and DZ twin data. Ann Hum Genet (2001) 1.55
Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study. Br J Cancer (2012) 1.55
Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol (1999) 1.55
Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer (1993) 1.55
Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab (1996) 1.53
Cervical cancer screening: a comparison of recruitment strategies among older women. Med J Aust (1991) 1.51
Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol (2001) 1.51
Adherence to asthma management guidelines by middle-aged adults with current asthma. Thorax (2009) 1.50
A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int (1998) 1.50
Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol (1996) 1.46
The role of SMAD4 in early-onset colorectal cancer. Colorectal Dis (2009) 1.45
Cerebral hypoperfusion in stroke prognosis and brain recovery. Stroke (1993) 1.44
The contribution of mortality statistics to the study of multiple sclerosis in Australia. J Neurol Neurosurg Psychiatry (1989) 1.44
Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countries. Occup Environ Med (2011) 1.43
Visualizing age-period-cohort trend surfaces: a synoptic approach. Int J Epidemiol (1992) 1.42
Cancer diagnosis after a report of negative cervical cytology. Med J Aust (1996) 1.42
Validation of short term recall of mobile phone use for the Interphone study. Occup Environ Med (2006) 1.42
Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion. Diabetologia (2003) 1.42
The relationship between maternal use of heroin and methadone and infant birth weight. Addiction (1997) 1.41
HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years. J Natl Cancer Inst (1999) 1.40
The management of testicular cancer in Victoria, 1988-1993. Urology Study Committee of the Victorian Co-operative Oncology Group. Med J Aust (2001) 1.39
The Australian NHMRC Twin Registry. A resource for the Australian scientific community. Med J Aust (1986) 1.39